title: Importance of blood clotting tests in the diagnosis of haemolytic-uremic syndrome and experience with its treatment.
abstract: More than half of 33 children with HUS were less than a year old, 90% less than five. A constant laboratory finding was the presence of FDP in the blood and urine, and of the remaining tests the presence of erythrocyte fragments. The absence of thrombocytopenia does not eliminate HUS. Antiplatelet treatment was given to 94% of children, heparin to 94%, thrombolysis to 27% Precise evaluation of treatment would require a controlled prospective multicentre study.
authors: Department of Clinical Haematology, Pediatric Teaching Hospital, Brno, CSSR.
authors: S
authors: S
authors: Valnícek
authors: J
authors: J
authors: Dolezel
authors: J
authors: J
authors: Hrubanová
authors: M
authors: M
authors: Habancová
authors: J
authors: J
authors: Stejskal
mesh_terms: D001780:Blood Coagulation Tests; D002675:Child, Preschool; D004176:Dipyridamole / Q000627:therapeutic use; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D006403:Hematologic Tests; D006463:Hemolytic-Uremic Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007223:Infant; D013300:Streptokinase / Q000627:therapeutic use
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D004176:Dipyridamole; D013300:Streptokinase; D006854:Hydrocortisone